Karen Flynn

Karen Flynn

Directeur/Membre du Conseil chez STEVANATO GROUP S.P.A.

Fortune : 946 391 $ au 30/06/2026

63 ans
Health Technology
Consumer Services
Finance

Profil

Ms. Karen A. Flynn is an Independent Director at Stevanato Group SpA, an Independent Director at Sotera Health Co., an Independent Director at Quanterix Corp., a Member at Healthcare Businesswomens Association and a Member at The Forum of Executive Women.
She is on the Board of Directors at Stevanato Group SpA, Sotera Health Co., Quanterix Corp., Germfree Laboratories LLC and The Franklin Institute.
Ms. Flynn was previously employed as a Chief Commercial Officer & Senior Vice President by Catalent, Inc., an Independent Director by Recro Pharma, Inc., a Chief Commercial Officer & Senior Vice President by West Pharmaceutical Services, Inc., a President-Biomodalities by Catalent Pharma Solutions, Inc., a Controller by MDeverywhere, Inc., a Principal by New York Life Insurance Co., a Principal by Sculptor Capital Management, Inc., and a Principal by The Bank of New York Co., Inc. She also served on the board at Catalent, Inc. and Chester County Economic Development Council.
She received her undergraduate degree from the University of Notre Dame, a graduate degree from the University of Pennsylvania and an MBA from Boston University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/05/2026 39 221 ( 0,01 % ) 696 173 $ 30/06/2026
15/04/2026 33 840 ( 0,07 % ) 146 189 $ 30/06/2026
15/06/2026 5 757 ( 0 % ) 104 029 $ 30/06/2026

Postes actifs de Karen Flynn

SociétésPosteDébut
QUANTERIX CORPORATION Directeur/Membre du Conseil 06/06/2022
SOTERA HEALTH COMPANY Directeur/Membre du Conseil 13/11/2023
STEVANATO GROUP S.P.A. Directeur/Membre du Conseil 22/05/2024
Directeur/Membre du Conseil -
The Forum of Executive Women
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de Karen Flynn

SociétésPosteFin
CATALENT, INC. Directeur/Membre du Conseil 25/01/2024
Corporate Officer/Principal 01/10/2023
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Karen Flynn

Formation de Karen Flynn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Finance

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Finance

Technology Services

Finance

Health Technology

Commercial Services

The Forum of Executive Women

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Karen Flynn
🔇